Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDUAL: Dolutegravir/Lamivudine in ART-Naïve Pregnant Women
NCT07616739Phase 4Recruiting
- Sponsor
- Fundación Huésped
- Start
- Sep 2026
- Primary completion
- Oct 2028
- Countries
- 2
01
Overview
A Phase 4 trial of dolutegravir, lamivudine in human immunodeficiency virus infection (HIV), sponsored by Fundación Huésped. Started Sep 2026; status: recruiting.
02
Drugs
dolutegravirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07616739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616739.